Patents by Inventor Fa-Xiang Ding

Fa-Xiang Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
    Publication number: 20100197691
    Abstract: Compounds of the Formula: (I) as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating hypertension, diabetes, inflammation, atherosclerosis, pain, and the like are disclosed. Pharmaceutical compositions and methods of use are also included.
    Type: Application
    Filed: July 11, 2008
    Publication date: August 5, 2010
    Inventors: Steven L. Colletti, Hong Shen, Fa-Xiang Ding
  • Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
    Publication number: 20100144778
    Abstract: The present invention encompasses compounds of Formula (I): as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.
    Type: Application
    Filed: June 26, 2006
    Publication date: June 10, 2010
    Inventors: Subharekha Raghavan, Steven L. Colletti, Fa-Xiang Ding, Hong Shen, James R. Tata, Ashley Rouse Lins, Abigail Lee Smenton, Weichun Chen, Darby Rye Schmidt, George Scott Tria
  • 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I
    Patent number: 7629376
    Abstract: The present invention discloses and claims compounds of formula (I) and formula (II) as inhibitors of human casein kinase I?, and methods of using the compounds of formula (I) and formula (II) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. The R-group substituents are defined herein and pharmaceutical compositions comprising compounds of formula (I) or formula (II) are also disclosed and claimed.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: December 8, 2009
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: William Arthur Metz, Jr., Fa-Xiang Ding
  • Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
    Publication number: 20090170891
    Abstract: The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.
    Type: Application
    Filed: April 6, 2007
    Publication date: July 2, 2009
    Inventors: Steven L. Colletti, James R. Tata, Weichun Chen, Richard T. Beresis, Fa-Xiang Ding, Darby Rye Schmidt, Hong Shen, Subharekha Raghavan
  • 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I
    Publication number: 20090082340
    Abstract: The present invention discloses and claims methods for the treatment of a patient suffering from a disease or disorder ameliorated by inhibition of casein kinase I? activity comprising the administration of a compounds of formula (I) and formula (II) as inhibitors of human casein kinase I?, and methods of using said compounds of formula (I) and formula (II) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. The R-group substituents are defined herein and pharmaceutical compositions comprising compounds of formula (I) or formula (II) useful in the claimed methods of treatment are also disclosed.
    Type: Application
    Filed: November 12, 2008
    Publication date: March 26, 2009
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: William Arthur METZ, JR., Fa-Xiang Ding
  • Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
    Publication number: 20090042926
    Abstract: The present invention encompasses compounds of Formula (I): as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.
    Type: Application
    Filed: December 20, 2006
    Publication date: February 12, 2009
    Inventors: Jason Imbriglio, Steven L. Colletti, James R. Tata, Richard T. Beresis, Daria Marley, Subharekha Raghavan, Darby Rye Schmidt, Ashley Rouse Lins, Abigail L. Smenton, Weichun Chen, Hong Shen, Fa-Xiang Ding, Rena Bodner
  • 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I
    Publication number: 20080027124
    Abstract: The present invention discloses and claims compounds of formula (I) and formula (II) as inhibitors of human casein kinase I?, and methods of using said compounds of formula (I) and formula (II) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. The R-group substituents are defined herein and pharmaceutical compositions comprising compounds of formula (I) or formula (II) are also disclosed and claimed.
    Type: Application
    Filed: February 13, 2007
    Publication date: January 31, 2008
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: William METZ, Fa-Xiang DING
  • Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
    Publication number: 20070299101
    Abstract: The present invention relates to niacin receptor agonists of formula: (I); as well as pharmaceutically acceptable salts and solvates. The compounds are useful for treating dyslipidemias, and in particular, reducing serum LDL, VLDL and triglycerides, and raising HDL levels. Pharmaceutical compositions and methods of treatment are also included.
    Type: Application
    Filed: October 31, 2005
    Publication date: December 27, 2007
    Inventors: Steven Colletti, Richard Beresis, Weichun Chen, James Tata, Hong Shen, Daria Marley, Qiaolin Deng, Jessica Frie, Fa-Xiang Ding
  • Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
    Publication number: 20070281969
    Abstract: The present invention encompasses compounds of Formula (I); as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.
    Type: Application
    Filed: November 18, 2005
    Publication date: December 6, 2007
    Inventors: Steven Colletti, James Tata, Hong Shen, Fa-Xiang Ding, Jessica Frie, Jason Imbriglio, Weichun Chen
  • Niacin receptor agonists, compositions containing such compounds and methods of treatment
    Publication number: 20060293364
    Abstract: The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.
    Type: Application
    Filed: June 26, 2006
    Publication date: December 28, 2006
    Inventors: Subharekha Raghavan, Steven Colletti, Fa-Xiang Ding, Hong Shen, James Tata, Ashley Lins, Abigail Smenton, Weichun Chen, Darby Schmidt, George Tria